{"filing":{"accession_number":"0000885978-26-000057","cik":"0000885978","ticker":"USPH","company_name":"U S PHYSICAL THERAPY INC /NV","form":"8-K","filing_date":"2026-09-21","report_date":"2026-09-15","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/885978/000088597826000057/form8-k.htm"},"events":[{"id":34013,"run_id":31310,"accession_number":"0000885978-26-000057","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the Board's approval on September 15, 2026, of Ms. Myra Davis's appointment to serve as a director effective October 1, 2026. The principal disclosed action is a person taking a board role. While the filing mentions she will receive standard director compensation (annual cash retainer and equity grant per the company's established director compensation policy), the core event is the appointment itself, not a compensatory arrangement modification. This is material to investors as board composition affects governance and strategic direction.","company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","filing_date":"2026-09-21","form":"8-K","submitted_at":null,"items":[{"id":37627,"accession_number":"0000885978-26-000057","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the Board's approval on September 15, 2026, of Ms. Myra Davis's appointment to serve as a director effective October 1, 2026. The principal disclosed action is a person taking a board role. While the filing mentions she will receive standard director compensation (annual cash retainer and equity grant per the company's established director compensation policy), the core event is the appointment itself, not a compensatory arrangement modification. This is material to investors as board composition affects governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:21:57.399172+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37627,"accession_number":"0000885978-26-000057","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the Board's approval on September 15, 2026, of Ms. Myra Davis's appointment to serve as a director effective October 1, 2026. The principal disclosed action is a person taking a board role. While the filing mentions she will receive standard director compensation (annual cash retainer and equity grant per the company's established director compensation policy), the core event is the appointment itself, not a compensatory arrangement modification. This is material to investors as board composition affects governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:21:57.399172+00:00","company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","filing_date":"2026-09-21"}]}